{
    "organizations": [],
    "uuid": "bb0f2341d4ab954851e14d80d2b0e8d24accb256",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amgen-receives-chmp-positive-opini/brief-amgen-receives-chmp-positive-opinion-to-add-updated-overall-survival-data-to-kyprolis-label-idUSASB0C30B",
    "ord_in_thread": 0,
    "title": "BRIEF-Amgen Receives CHMP Positive Opinion To Add Updated Overall Survival Data To Kyprolis Label",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Amgen Inc:\n* AMGEN RECEIVES CHMP POSITIVE OPINION TO ADD UPDATED OVERALL SURVIVAL DATA TO KYPROLISÂ® (CARFILZOMIB) LABEL Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T16:21:00.000+02:00",
    "crawled": "2018-01-30T16:32:30.035+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "amgen",
        "inc",
        "amgen",
        "receives",
        "chmp",
        "positive",
        "opinion",
        "add",
        "updated",
        "overall",
        "survival",
        "data",
        "carfilzomib",
        "label",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}